ArdamanPal KaurShergillMD

Oncology • Chicago, IL

Hematologic Oncology

Physician

Join to view full profile

Dr. Shergill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shergill's full profile

Already have an account?

Office
5841 S Maryland Ave
Chicago, IL 60637
Phone+1 888-824-0200

Fax+1 773-702-4274

Summary

Dr. Ardaman Shergill is an oncologist in Chicago, IL. She received her medical degree from Wayne State University School of Medicine and has been in practice 8 years. She specializes in hematologic oncology and is experienced in gastrointestinal oncology and thoracic oncology.

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2011 - 2013
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine/Pediatrics, 2009 - 2011
Wayne State University School of MedicineClass of 2009

Certifications & Licensure

IL State Medical License 2012 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma.
Gertruda Evaristo, Carla Harmath, Jeremy P Segal, Ardaman Shergill, Namrata Setia
Cancer Reports. 2024-12-01
Phase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017.
Muhammad Furqan, Jyoti Malhotra, Ardaman Shergill, Li Liu, Sarah L Mott
Translational Lung Cancer Research. 2024-11-30
5 citations
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.
Jennifer A Chan, Susan Geyer, Tyler Zemla, Michael V Knopp, Spencer Behr
The New England Journal of Medicine. 2024-09-16

Lectures

A Multi-Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Rela...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018